With prospects distracted by the epidemic, ABM requires personalization. A SiriusDecisions VP says "generic marketing" won't work. How can you use ABM neuromarketing to personalize content, engage prospects, and improve lead conversion rates?
The London School of Business verified that buyers retain 70% of an effective sales story and only 5% of factual value propositions. This is even more true during a pandemic. If your competitors are better storytellers, they’re remembered and get the sale.
Sales leaders say that creating value and insights during the prospect conversation stage is their biggest challenge, especially when they can't meet in person. Reps that spend hours on portals trying to find content have 21% lower lead acceptance and 36% less lead conversion.
If you had a team of award-winning writers, consultants, and neuroscientists editing copy and coaching your team, could you increase engagement by 216%?
If you had Certified Advanced ABM Strategists & New York Times bestselling storytellers could you increase customer retention and engagement by 1400%?
If you had interactive, personalized, and just-in-time sales playbooks, could your reps teach, tailor, and take control to improve lead conversion rates by 312%?
Copyright © 2020 Aretanium Executive Group, Inc. dba REMOTELYME. Aretanium, REMOTELYME, REMOTE86, LEADWELL86, BRAINSCORE86, LEADER86, NEURO86, ACTION86, ACTIVE86, ENGAGE86, and FROG86 are trademarks of Aretanium Executive Group, Inc. All Rights Reserved. Please read our Terms of Service prior to using any REMOTELYME App or Site.